Screen the market. Value any stock.

Neither. ACCE is a research platform. we publish indices, stock picks, and analysis that you execute in your own brokerage account (Interactive Brokers, Schwab, Trade Republic, whichever you prefer). We are not a registered investment adviser, and nothing on ACCE is personalized financial advice. Think of us as the research desk; your brokerage is the trading desk.

Each index is a curated basket of stocks organized around a thesis: AI Infrastructure, Defense, Cybersecurity, and so on. Our analysts build and maintain every index. AI assists with research and screening, but a human makes the final call on every constituent, weight, and rebalance. We publish the full methodology, track daily NAV against the S&P 500, and rebalance on triggers, not calendars. You do not buy the index. You follow it and replicate the positions that match your risk profile.

Free gives you 3 full stock pages every month (the 6-model valuation and complete data surface), then teaser-only stock pages with the ACCE score and earnings / filings, plus index performance, headlines, and basic screener access. Investor unlocks full theses (7-day delayed), score breakdowns, the full stock-detail surface (8-quarter beat/miss chart, SEC filings timeline with narrated summaries, press releases archive, 5-metric fundamental charting, management quality with named officers and insider activity), portfolio tracking (10 holdings), and the weekly digest. Pro removes the delay, adds the systematic 6-model valuation engine (DCF, reverse DCF, P/E and EV/EBITDA comps, Graham number, dividend discount), the customizable DCF workbench with saved scenarios, our narrated enriched thesis (narrative risk, consensus blind spots, catalysts), full 19-metric fundamental charting with analyst forecast cones, full screener, unlimited portfolio positions, portfolio insights, and stock-page PDF research reports. Desk layers on power-user tools, multi-stock comparison, private notes per stock, equation screener, Monte Carlo simulation, correlation matrix, tax-loss harvesting, monthly + quarterly review emails, and priority support. Researcher is a parallel track between Investor and Pro: same Pro-grade data engine (6-model valuation, DCF workbench, enriched thesis, full screener) but no weekly picks and no thematic indices, for investors who want the data and make their own selections. Most active investors end up on Pro within two weeks; Desk is for users who treat investing as a discipline.

Every stock page is a one-stop research surface: ACCE score (Growth / Value / Quality / Momentum breakdown), price chart, 8-quarter earnings beat/miss visualisation, SEC filings timeline with narrated bullet summaries (10-K, 10-Q, 8-K, Form 4, proxy), press releases archive, management quality blurb grounded in named officers, total pay and 12-month insider activity, multi-currency display, and a fundamental-trends chart covering 19 metrics across 5 years quarterly + annual (with analyst forecast cone on Pro). Pro tier adds the systematic 6-model valuation grid, the customizable DCF workbench, the narrated enriched thesis, and a downloadable PDF research report.

Every claim is grounded in current price, market cap, and the output of our systematic 6-model valuation engine for that stock. The model that writes the thesis is locked to four specific tasks: identify where consensus is likely wrong, the narrative risks the systematic models cannot capture, qualitative catalysts that could re-rate the stock, and what would actually invalidate the thesis. It complements the deterministic valuation, it is not a general-purpose chatbot, and it cannot quote numbers we have not given it.

A human does the work, with AI assisting. Our models handle the heavy quantitative lifting (screening thousands of stocks, running financial models, scoring fundamentals and momentum) so the analyst can focus on judgment: verifying the thesis, weighing the catalyst, and signing off on every published pick, index rebalance, and constituent change.

Every Sunday at 07:00 UTC we publish 2–3 conviction picks. Each one includes the full thesis, entry price, target, stop-loss, time horizon, and the specific catalyst we're playing. Pro and Desk subscribers receive them immediately; Investor subscribers see the full thesis 7 days later. Outcomes are tracked publicly. you can see the full archive with every win and every loss.

Win if the closed return is positive. Loss if negative. That is it. The hit rate updates automatically from closed picks and the full archive is public, so nothing can be massaged after the fact.

Global equities across US, European, Canadian, and Asia-Pacific exchanges — NYSE, NASDAQ, LSE, XETRA, Euronext (Paris/Amsterdam/Brussels), SIX Swiss, Borsa Italiana, BME (Madrid), Nordic exchanges, TSX, Tokyo, Hong Kong, ASX, Singapore, Taiwan, Korea, and NSE (India). The screener carries thousands of names across these markets, with ~80 curated for deep research coverage and index inclusion. SEC EDGAR filings auto-attach to any dual-listed foreign filer; full per-regulator local filing integration (BaFin, AMF, SEDAR+, EDINET, ASX disclosures, HKEX, etc.) is on the roadmap.

Equities only. We focus on stocks because that's where our quantitative models and fundamental analysis add the most value. We have no plans to cover crypto or derivatives. there are better tools for those if that's what you need.

No. Any brokerage that gives you access to the relevant exchange works — Interactive Brokers, Schwab, Trade Republic, Degiro, Saxo, whatever you already use. Interactive Brokers tends to offer the broadest international access at the lowest cost; Trade Republic and Degiro are strong in Europe; Schwab/Fidelity for US-focused investors. Make sure your broker covers the listing venues you care about (e.g. LSE for UK names, XETRA for German, TSX for Canadian).

Everything runs on UTC. Weekly picks publish Sunday 07:00 UTC. Cron jobs (price updates, position monitoring, stop-loss checks) run daily between 21:00–23:00 UTC, after US market close. Email digests send Monday 08:00 UTC. All timestamps in the app are displayed in your local time zone.

The entry price is a reference point, not a limit order. If you're within 2–3% of the published entry, the thesis and risk/reward setup are still intact. If the stock has already moved 5%+ past entry by the time you see it, the risk/reward has shifted and you should evaluate independently. We note the entry price at publication time so you can judge for yourself.

Most picks have a 2–8 week time horizon, stated upfront in the thesis. Some catalyst-driven trades resolve in days; macro-thematic positions can run longer. The position monitor checks daily and will trigger a close (win, loss, or expired) when conditions are met. Average holding period across all closed picks is displayed on the picks page.

Yes. Investor and Pro users can upload a CSV or Excel file with your transactions (ticker, date, buy/sell, shares, price, fees). We provide a template. The system auto-backfills dividends and stock splits, computes cost basis, and gives you a full P&L view. Pro users also get insights on concentration, sector balance, and overlap with ACCE indices.

You shouldn't trust it blindly. that's why we publish everything. Every pick, every outcome, every return is public and timestamped. We can't retroactively edit or delete closed positions. The track record is short because we're new, and we won't pretend otherwise. What we can promise is that every data point is real, verifiable, and will build over time. Judge us on transparency, not tenure.

Policy and architecture. All picks are generated and queued before publication. The publication timestamp is system-generated and immutable. Our team members are prohibited from trading any stock that appears in the pick pipeline within 48 hours before or after publication. We don't manage money, so there's no fund to front-run into. If we ever violate this, the public archive is the evidence.

No. Zero. We don't accept payment, sponsorship, or any form of compensation from companies featured in our indices, picks, or analysis. Revenue comes exclusively from subscriptions. If a company offered us money to cover them, we'd decline and probably write about why.

Three things: methodology, accountability, and incentives. We publish the full thesis and financial model behind every call. not just "buy this." Every outcome is tracked publicly with real returns, not screenshots of winners. And our revenue comes from subscriptions, not engagement, sponsorships, or affiliate deals. We make more money when subscribers stay because the research is good, not because the content is viral.

Yes. Every closed pick. win or loss. stays in the public archive with the full thesis, entry/exit prices, and actual return. We don't delete losses, edit them after the fact, or bury them. The hit rate and average return update automatically. If we're wrong, you'll see it in the numbers alongside everyone else.

Pro and Researcher both unlock the full data engine on screener and stock pages: the 6-model systematic valuation, the customizable DCF workbench, the narrated enriched thesis, 19-metric fundamental charting with analyst forecast cone, downloadable PDF research reports, the full screener with unlimited saved screens and CSV export, and unlimited portfolio positions. Pro layers the editorial product on top: weekly conviction picks (real-time, with full thesis and entry/target/stop), thematic indices with daily NAV and full performance attribution, the rebalance plan, broker auto-import via SnapTrade, and the weekly digest. Researcher is for investors who want the data and the models but make their own selections. No picks, no indices, $9/mo vs Pro's $20/mo.

Yes. Open your profile, go to Plans & Billing, and manage or cancel your subscription through the Stripe billing portal. You keep access through the end of your current billing period, then drop to Free. Annual plans cancel at the end of the year.

No refunds. Every paid plan comes with a 14-day trial (card required) so you can test the product before being charged. Cancel any time during the trial and you pay nothing. After the trial, cancel any time to stop future billing (you keep access until the current period ends).

Yes. All paid plans include a 14-day trial. Your card is collected when you start it but you won't be charged until the trial ends. Cancel anytime during the trial and pay nothing. There is also a free account, no card required: you get 3 full stock pages every month plus the screener and index performance, free forever.

Yes. ACCE is a research and information platform, not a broker or advisor. You can subscribe from any country. Coverage spans US, European, Canadian, and Asia-Pacific exchanges, so subscribers worldwide find names listed where they actually trade. Your ability to buy any specific stock depends on your local brokerage and regulations. Check with your broker if you're unsure about access to specific markets.

Your portfolio data and saved screens are retained for 90 days after cancellation in case you resubscribe. After that, they're permanently deleted. Your account email and subscription history are retained for legal/accounting purposes. You can request full data deletion at any time via email. we comply within 72 hours. We're GDPR-compliant: no data selling, no third-party sharing, no ad targeting.

If we ever wind down, active subscribers get at least 30 days notice and a prorated refund on any unused subscription period. You'd be able to export all portfolio data and saved screens as CSV before shutdown. The pick archive would remain accessible as a static page for at least 12 months. We're a funded, revenue-generating business. but you deserve to know the contingency plan.